Biostatistics
Submitted by Anonymous (not verified) on 16 February 2024 - 11:55
Biostatistics
Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions (according to Regulation (EU) 2019/6)
Submitted by Anonymous (not verified) on 16 February 2024 - 10:25
Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions (according to Regulation (EU) 2019/6)
Records of data processing activity (public) for the HMA-EMA Catalogue of real-world data sources (and networks and institutions)
Submitted by Anonymous (not verified) on 15 February 2024 - 16:02
Records of data processing activity (public) for the HMA-EMA Catalogue of real-world data sources (and networks and institutions)
European Medicines Agency's Data Protection Notice for the HMA-EMA Catalogue of real-world data sources (and networks and institutions)
Submitted by Anonymous (not verified) on 15 February 2024 - 15:57
European Medicines Agency's Data Protection Notice for the HMA-EMA Catalogue of real-world data sources (and networks and institutions)
European Medicines Agency’s Data Protection Notice for the HMA-EMA Catalogue of real-world data studies
Submitted by Anonymous (not verified) on 15 February 2024 - 15:55
European Medicines Agency’s Data Protection Notice for the HMA-EMA Catalogue of real-world data studies
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Submitted by Anonymous (not verified) on 15 February 2024 - 15:34
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Veterinary medicines European public assessment report (EPAR): CircoMax, Porcine circovirus vaccine (inactivated recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 15 February 2024 - 15:27
Veterinary medicines European public assessment report (EPAR): CircoMax, Porcine circovirus vaccine (inactivated recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Brucellin Aquilon, Status: Authorised
Submitted by Anonymous (not verified) on 15 February 2024 - 15:23
Veterinary medicines European public assessment report (EPAR): Brucellin Aquilon, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Vectormune ND, Newcastle disease and Marek’s disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 15 February 2024 - 14:43
Veterinary medicines European public assessment report (EPAR): Vectormune ND, Newcastle disease and Marek’s disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): AdTab (previously Lotilaner Elanco), lotilaner, Status: Authorised
Submitted by Anonymous (not verified) on 15 February 2024 - 13:37
Veterinary medicines European public assessment report (EPAR): AdTab (previously Lotilaner Elanco), lotilaner, Status: Authorised